CARB-X CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well. CARB-X Awards GenomeKey Up to $9.5M to Develop Rapid Diagnostic Test for Sepsis GenomeKey's technology combines methods to separate bacterial and human DNA, next-generation sequencing, and machine learning. Baebies Awarded up to $11.6M in CARB-X Funding for Neonatal Sepsis Test The rapid, point-of-care test is being developed to run on the Durham, North Carolina-based company's Finder digital microfluidics instrument. CARB-X Commits up to $13.8M to Novel Microdevices for Point-of-Care STI Test Novel Microdevices is developing a portable, sample-to-answer instrument that is designed to perform molecular testing on untreated patient samples. Breaking News Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships Canadian Government, Partners Commit C$59.8M to Natural Resources, Environmental Genomics Projects People in the News: New Appointments at Element Biosciences, Sema4, OriCiro Genomcs, More New Products Posted to GenomeWeb: Thermo Fisher, Paradigm4, Applied Cells, More In Brief This Week: Caribou Biosciences, AnchorDx, Neogen, Microbiome Insights, More Cytek Biosciences Prices $200M Initial Public Offering The Scan Shape of Them All According to BBC News, researchers have developed a protein structure database that includes much of the human proteome. For Flu and More The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza. To Boost Women China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post. Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.